Explore more about: Biomolecular materials

August 14, 2020
News
A team has developed a class of light-switchable, highly adaptable molecular tools with new capabilities to control cellular activities. The antibody-like proteins, called OptoBinders, have potential applications including protein purification, the improved production of biofuels, and new types of targeted cancer therapies.
March 23, 2020
News
Biological engineers have created a multitissue model that lets them study the relationships between different organs and the immune system on a microfluidic chip seeded with human cells. With this 'organs-on-a-chip' model, they could explore the role of immune cells in ulcerative colitis and other inflammatory diseases.
January 24, 2020
News
Millions of people are treated with antibiotics each year for infections or as a preventative measure. Two teams of NIBIB-funded scientists have been working to find alternative solutions for treating bacterial infections, especially antibiotic-resistant bacteria.
December 3, 2020
News
An NIH-funded team at the University of Colorado (UC) has assembled a clearer picture of the molecular activity that occurs when nanoparticles injected into the body are marked for immune system attack.
December 3, 2020
News
Nanogenerator’s electrical pulses provide beneficial outcomes with no side effects – rat study.
December 7, 2020
News
NIBIB funded researchers have developed laser-activated nanomaterials that integrate with wounded tissues to form seals that are superior to sutures for containing body fluids and preventing bacterial infection.
June 29, 2021
News
Pulmonary fibrosis is one of the most common and serious types of lung disease. Now NIBIB-funded researchers have developed an in vitro lung tissue-on-a-chip system that mimics lung fibrosis, offering rapid testing of potential new anti-fibrotic treatments.
December 7, 2020
News
Shape Memory Medical recently announced FDA clearance for U.S. marketing of their IMPEDE Embolization Plug, a technology funded by the National Institute of Biomedical Imaging and Bioengineering and created to block irregular blood vessels.
December 3, 2020
News
Bioengineers at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed a smart anti-cancer nanoparticle with precisely targeted tumor-killing activity superior to previous technologies.
December 9, 2020
News
When cardiovascular disease causes blocked blood vessels, tissues die because the oxygen carried by blood cells cannot reach the tissue. Surgery can remove blockages in large vessels in the heart or legs but is not possible in small vessels. To address this problem, researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) designed 3D-printed patches seeded with vessel-inducing endothelial cells in various geometric patterns. Using a mouse model of hindlimb ischemia, the researchers identified specific patch patterns that induced growth of organized, tissue-saving blood vessels, demonstrating the potential for the novel technology to address this significant public health problem.